2024 ASHA Comments and Testimony

Below is a list of comments, letters, and testimony submitted on issues related to ASHA's 2024 Public Policy Agenda.

All documents are in PDF format. You will need Adobe Acrobat Reader or another PDF reader to see or print them. Acrobat Reader is free and may be downloaded from the Adobe website.

See also: 2023 ASHA Comments and Testimony

• ASHA Response to Department of Education on Data Related to Early Childhood Education Providers (July 22, 2024)
• ASHA Letter to Oregon on "Purport to Be" Language in the Oregon Speech-Language Pathology and Audiology Statutes (June 1, 2024)
• ASHA Comments to the Department of Education on the State Personnel Development Grants Program (April 29, 2024)
• ASHA Support Letter to Oregon on Speech-Language Stipend Program (April 10, 2024)
• ASHA Letter to U.S. Department of Labor on Proposed Rule to Improve Capacity of the National Apprenticeship Program (March 18, 2024)
• ASHA Letter to Oklahoma Legislators on HB 1037, Salary Bonus for School-Based Audiologists and SLPs (March 8, 2024)
• ASHA Letter to House Education and Workforce Committee on College Cost Reduction Act (March 1, 2024)
• ASHA Feedback for U.S. Department of Education's Notice on Comprehensive Centers (February 21, 2024)
• Coalition Letter of Support for Dr. Lorna Breen Health Care Provider Protection Reauthorization Act (February 15, 2024)
• ASHA Support Letter of Dr. Lorna Breen Health Care Provider Protection Reauthorization Act (February 13, 2024)
• ASHA Support Letter to Maryland Regarding HB 789 for Audiologist and Speech-Language Pathologist Salary Supplements (February 7, 2024)
• ASHA Support Letter to Utah Regarding HB 103 for Audiologist and Speech-Language Pathologist Salary Supplement (February 1, 2024)

• Joint Therapy Group Letter to Congressional Leaders on Telehealth (December 6, 2024)
• ASHA Comments on the 2026 HHS Notice of Benefit and Payment Parameters Proposed Rule (November 12, 2024)
• Joint Letter to CMS Requesting Meeting to Discuss UnitedHealthcare Prior Authorization Policy (November 4, 2024)
• ASHA Support Letter to ICD-10-CM Committee Regarding New Primary Progressive Apraxia of Speech Code (October 24, 2024)
• AOTA, APTA, and ASHA Joint Letter to UnitedHealthcare on Prior Authorization Policy (October 16, 2024)
• ASHA Comments to CMS on MAC Consolidation Request for Information (September 27, 2024)
• Joint Letter to UnitedHealthcare on Prior Authorization (September 23, 2024)
• ASHA Letter of Support Regarding Pennsylvania HB 2268 on Stuttering Coverage (September 13, 2024)
• ASHA Comments on Senate HELP Committee Consolidation Hearing (September 11, 2024)
• ASHA Member Petition to CMS to Continue Audiology and Speech-Language Pathology Telehealth Services in 2025 (September 9, 2025)
• ASHA Comments to CMS on Proposed 2025 Medicare Physician Fee Schedule (September 9, 2024)
• ASHA Comments to CMS on Proposed Outpatient Prospective Payment System Rule (September 3, 2024)
• ASHA Comments to CMS on 2025 Home Health Proposed Payment System Proposed Rule (August 26, 2024)
• ASHA Letter to Highmark Pennsylvania Expressing Concern Over Payment Cuts (August 9, 2024)
• ASHA Letter to CMS on Alternative Payment Model Updates and the Increasing Organ Transplant Access Model (July 15, 2024)
• ASHA Letter to Anthem Connecticut Regarding Payment Structure Change (July 12, 2024)
• ASHA Letter to Medicare Contractors Regarding Draft LCD Dysphonia Botulinum Toxin Injections Coverage (July 12, 2024)
• ASHA Letter to House Ways and Means Subcommittee Regarding Hearing on Improving Value-Based Care (July 10, 2024)
• ASHA Letter to Wyoming on Updating Prior Authorization Requirements for the Federal Employee Program (July 2, 2024) 
• Rehabilitation Therapy Coalition Letter to Senate Finance Regarding Medicare Payment Reform (June 14, 2024)
• Joint Letter from ASHA, AAA, and ADA to Senate Finance Regarding Medicare Payment Reform (June 14, 2024)
• Audiology Quality Consortium Letter to Senate Finance Committee Regarding Medicare Payment Reform (June 14, 2024)
• ASHA Comments on Long-Term Care Hospital Prospective Payment System Proposed Rule for 2025 (June 10, 2024)
• ASHA Letter to Pennsylvania in Support of HB 2268 Regarding Stuttering Coverage (June 5, 2024)
• ASHA Letter to Ohio in Support of Madeline's Law (May 29, 2024)
• ASHA Comments to CMS on Prospective Payment System and Consolidated Billing for Skilled Nursing Facilities for 2025 (May 28, 2024)
• ASHA Comments to CMS on Inpatient Rehabilitation Facility Prospective Payment System for Federal Fiscal Year 2025 (May 28, 2024)
• ASHA Letter to the Committee on Energy and Commerce, Subcommittee on Health on Making Audiology and Speech-Language Pathology Telehealth Services Permanent (May 16, 2024)
• ASHA Letter to the Committee on Ways and Means on Making Audiology and Speech-Language Pathology Telehealth Services Permanent (May 8, 2024)
• ASHA Sample Letter to Multiple Insurance Companies Regarding Diagnosis Code Classifications (May 2024)
• ASHA and VSHA Joint Letter to Vermont on H.766 Regarding Streamlining Prior Authorization Practices (April 19, 2024)
• Therapy Coalition Joint Letter to House Subcommittee on the Expanded Telehealth Access Act (April 9, 2024)
• ASHA Letter to Kentucky on SB 111 Regarding Stuttering Coverage (March 12, 2024)
• ASHA Letter to Blue Cross Blue Shield Seeking Clarification on Federal Employee Program Utilization Management Guideline 005 (Hearing Aids) (March 8, 2024)
• ASHA Letter to Energy and Commerce Health Subcommittee on the Expanded Telehealth Access Act (February 13, 2024)
• ASHA Comments to CMS on Proposed Amendments to the No Surprises Act (February 5, 2024)
• ASHA Letter to CMS Regarding CY2025 Telehealth Services Request (February 1, 2024)
• ASHA Support Letter to Arizona Regarding HB 2112 to Expand Hearing Aid Coverage (January 26, 2024)
• ASHA Comments to Delaware on HB 273 Regarding Speech Therapy Coverage (January 15, 2024)
• ASHA Comments to CMS on 2025 HHS Notice of Benefit and Payment Parameters (January 8, 2024)
• ASHA Comments to CMS Regarding Medicare Advantage Plan NPRM (January 3, 2024)
• ASHA Letter to First Coast Florida Regarding Coverage for RTM and Laryngoscopy with Stroboscopy (January 3, 2024)

• ASHA Comments to Nevada on Speech-Language Pathology Assistant Regulations (October 28, 2024)
• ASHA Support Letter to Massachusetts on Provisional License Regulations (October 28, 2024)
• ASHA Opposition Letter to West Virginia on Expanding Hearing Aid Dispenser Scope of Practice (October 14, 2024)
• ASHA Letter of Support to New Mexico Speech-Language-Hearing Association on Speech-Language Pathology Assistant Licensure (October 3, 2024)
• ASHA Letter to House Energy and Commerce Committee Regarding NIH Reform Proposal (August 16, 2024)
• ASHA Comments to Michigan Department of Health and Human Services (August 14, 2024)
• ASHA Opposition Letter to Nevada Regarding NRS-637B.055 to Expand Hearing Aid Specialist Scope of Practice (July 29, 2024)
• ASHA Opposition Letter to the House on Section 247 of the Labor, Health and Human Services, Education, and Related Agencies Appropriations Act, Restricting Gender Affirming Voice Therapy (July 8, 2024)
• ASHA Letter to West Virginia on the Rules Governing Audiology and Speech-Language Pathology Assistants and Their Supervisors (June 28, 2024)
• ASHA Letter to Delaware Supporting SB 320 to License Speech-Language Pathology Assistants (June 17, 2024)
• ASHA Testimony to the Senate on the 2025 Labor, Health and Human Services, Education and Related Agencies Appropriations Bill (May 24, 2024)
• ASHA Comments on the Development of a Universal Symbol for Language Assistance Services in Health Settings (May 20, 2024)
• ASHA Comments on Medicare Advantage Data (May 20, 2024)
• ASHA Comments on Consolidation in Health Care Markets (May 6, 2024)
• ASHA Testimony to the House on the 2025 Labor, Health and Human Services, Education and Related Agencies Appropriations Bill (May 3, 2024)
• ASHA Letter of Support to Minnesota on ASLP-IC (March 26, 2024)
• ASHA Support Letter to Illinois on SB 3467 Regarding Speech-Language Pathology Assistants and Their Supervisors (March 6, 2024)
• ASHA Support Letter to Illinois on HB 5532 Regarding Speech-Language Pathology Assistants and Their Supervisors (March 6, 2024)
• ASHA Letter to Rhode Island on H 7388 Regarding Regulations Review (March 6, 2024)
• ASHA Support Letter to Minnesota on SF 2982 Regarding Speech-Language Pathology Assistant Protections (March 1, 2024)
• ASHA Letter to Maryland on HB464 Regarding Audiology Scope of Pratice Updates (February 23, 2024)
• ASHA Letter of Opposition to Nebraska on 407 Credentialing Review for Hearing Instrument Specialists (February 23, 2024)
• ASHA Comments to Maryland Regarding MSHA Opportunity to Submit Licensing Board Candidates Referral List (February 14, 2024)
• ASHA Response to Interagency Autism Coordinating Committee Request for Information (February 14, 2024)
• ASHA Support Letter to Oklahoma on Proposed SLPA Regulations (February 7, 2024)
• ASHA Opposition Letter to Alaska Regarding Proposed Sunrise Review Board Creation (February 1, 2024)
• ASHA Letter of Concern to New Jersey Regarding S 1073 on Deaf or Hard of Hearing Children (January 24, 2024)
• ASHA Letter to New Hampshire Regarding HB 1553 - Spelling to Communicate (January 17, 2024)
• ASHA Letter to South Dakota Regarding HB 1029 (January 17, 2024)
• ASHA Letter of Support to Florida SB 7106 Regarding ASLP-IC (January 11, 2024)